{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T01:25:10Z","timestamp":1790990710934,"version":"4.1.0"},"reference-count":39,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Journal of Bone and Joint Surgery"],"published-print":{"date-parts":[[2014,7,16]]},"DOI":"10.2106\/jbjs.m.00862","type":"journal-article","created":{"date-parts":[[2014,7,17]],"date-time":"2014-07-17T00:21:51Z","timestamp":1405556511000},"page":"e117","source":"Crossref","is-referenced-by-count":27,"title":["A Combination of rhBMP-2 (Recombinant Human Bone Morphogenetic Protein-2) and MEK (MAP Kinase\/ERK Kinase) Inhibitor PD0325901 Increases Bone Formation in a Murine Model of Neurofibromatosis Type I Pseudarthrosis"],"prefix":"10.2106","volume":"96","author":[{"given":"J.","family":"El-Hoss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.C.","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Deo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Mikulec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.G.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Schindeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"issue":"1","key":"bib1-20210131","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/01202412-200001000-00003","article-title":"Congenital pseudarthrosis of the tibia: history, etiology, classification, and epidemiologic data","volume":"9","author":"Hefti","year":"2000","journal-title":"J Pediatr Orthop B."},{"key":"bib2-20210131","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1097\/00003086-200208000-00013","article-title":"Orthopaedic manifestations of neurofibromatosis in children: an update","volume":"401","author":"Vitale","year":"2002","journal-title":"Clin Orthop Relat Res."},{"issue":"2","key":"bib3-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.2106\/00004623-199274020-00002","article-title":"Use of an intramedullary rod for the treatment of congenital pseudarthrosis of the tibia","volume":"74","author":"Anderson","year":"1992","journal-title":"J Bone Joint Surg Am."},{"issue":"6","key":"bib4-20210131","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.2106\/00004623-200406000-00010","article-title":"Use of an intramedullary rod for treatment of congenital pseudarthrosis of the tibia. A long-term follow-up study","volume":"86","author":"Dobbs","year":"2004","journal-title":"J Bone Joint Surg Am."},{"issue":"5","key":"bib5-20210131","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/01241398-199709000-00020","article-title":"Ilizarov technique in the treatment of congenital pseudarthrosis of the tibia","volume":"17","author":"Ghanem","year":"1997","journal-title":"J Pediatr Orthop."},{"issue":"2","key":"bib6-20210131","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11832-008-0084-2","article-title":"A tale of two tibias: a review of treatment options for congenital pseudarthrosis of the tibia","volume":"2","author":"Johnston","year":"2008","journal-title":"J Child Orthop."},{"issue":"10","key":"bib7-20210131","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.2106\/00004623-200210000-00010","article-title":"Congenital pseudarthrosis of the tibia: results of technical variations in the Charnley-Williams procedure","volume":"84","author":"Johnston","year":"2002","journal-title":"J Bone Joint Surg Am."},{"issue":"2","key":"bib8-20210131","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1097\/01.bpo.0000151054.54732.0b","article-title":"Treatment of congenital pseudarthrosis of the tibia: a multicenter study in Japan","volume":"25","author":"Ohnishi","year":"2005","journal-title":"J Pediatr Orthop."},{"key":"bib9-20210131","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00003086-199207000-00011","article-title":"Treatment of congenital pseudoarthrosis of the tibia using the Ilizarov technique","volume":"280","author":"Paley","year":"1992","journal-title":"Clin Orthop Relat Res."},{"issue":"6","key":"bib10-20210131","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1097\/01241398-199011000-00015","article-title":"Treatment of congenital pseudarthrosis of the tibia by the Ilizarov method","volume":"10","author":"Plawecki","year":"1990","journal-title":"J Pediatr Orthop."},{"issue":"1","key":"bib11-20210131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2106\/JBJS.H.01667","article-title":"The use of rhBMP-2 for the treatment of congenital pseudarthrosis of the tibia: a case series","volume":"92","author":"Richards","year":"2010","journal-title":"J Bone Joint Surg Am."},{"issue":"3","key":"bib12-20210131","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2106\/00004623-200603000-00023","article-title":"Treatment of congenital pseudarthrosis of the tibia with recombinant human bone morphogenetic protein-7 (rhBMP-7). A report of five cases","volume":"88","author":"Lee","year":"2006","journal-title":"J Bone Joint Surg Am."},{"issue":"1","key":"bib13-20210131","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1086\/504441","article-title":"Double inactivation of NF1 in tibial pseudarthrosis","volume":"79","author":"Stevenson","year":"2006","journal-title":"Am J Hum Genet."},{"issue":"6","key":"bib14-20210131","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/j.cmet.2006.10.010","article-title":"ATF4 mediation of NF1 functions in osteoblast reveals a nutritional basis for congenital skeletal dysplasiae","volume":"4","author":"Elefteriou","year":"2006","journal-title":"Cell Metab."},{"key":"bib15-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1741-7015-6-21","article-title":"Modelling neurofibromatosis type 1 tibial dysplasia and its treatment with lovastatin","volume":"6","author":"Kolanczyk","year":"2008","journal-title":"BMC Med."},{"issue":"20","key":"bib16-20210131","doi-asserted-by":"crossref","first-page":"3910","DOI":"10.1093\/hmg\/ddr310","article-title":"Mice lacking Nf1 in osteochondroprogenitor cells display skeletal dysplasia similar to patients with neurofibromatosis type I.","volume":"20","author":"Wang","year":"2011","journal-title":"Hum Mol Genet."},{"issue":"3","key":"bib17-20210131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/0896-6273(93)90324-K","article-title":"The neurofibromatosis type 1 gene and its protein product, neurofibromin","volume":"10","author":"Gutmann","year":"1993","journal-title":"Neuron."},{"issue":"1","key":"bib18-20210131","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jbmr.528","article-title":"A murine model of neurofibromatosis type 1 tibial pseudarthrosis featuring proliferative fibrous tissue and osteoclast-like cells","volume":"27","author":"El-Hoss","year":"2012","journal-title":"J Bone Miner Res."},{"issue":"5","key":"bib19-20210131","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/s00280-006-0323-5","article-title":"Pharmacodynamic and toxicokinetic evaluation of the novel MEK inhibitor, PD0325901, in the rat following oral and intravenous administration","volume":"59","author":"Brown","year":"2007","journal-title":"Cancer Chemother Pharmacol."},{"issue":"4","key":"bib20-20210131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.cell.2012.06.034","article-title":"ERK inhibition rescues defects in fate specification of Nf1-deficient neural progenitors and brain abnormalities","volume":"150","author":"Wang","year":"2012","journal-title":"Cell."},{"issue":"1","key":"bib21-20210131","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1172\/JCI60578","article-title":"MEK inhibition exhibits efficacy in human and mouse neurofibromatosis tumors","volume":"123","author":"Jessen","year":"2013","journal-title":"J Clin Invest."},{"issue":"1","key":"bib22-20210131","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1172\/JCI63193","article-title":"Sustained MEK inhibition abrogates myeloproliferative disease in Nf1 mutant mice","volume":"123","author":"Chang","year":"2013","journal-title":"J Clin Invest."},{"issue":"2","key":"bib23-20210131","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.bbrc.2005.09.198","article-title":"Osteoclasts but not osteoblasts are affected by a calcified surface treated with zoledronic acid in vitro","volume":"338","author":"Schindeler","year":"2005","journal-title":"Biochem Biophys Res Commun."},{"issue":"1-2","key":"bib24-20210131","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.jim.2007.11.013","article-title":"Use of Cre-adenovirus and CAR transgenic mice for efficient deletion of genes in post-thymic T cells","volume":"331","author":"Zha","year":"2008","journal-title":"J Immunol Methods."},{"issue":"11","key":"bib25-20210131","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/hum.2005.16.1287","article-title":"Novel compound enables high-level adenovirus transduction in the absence of an adenovirus-specific receptor","volume":"16","author":"Fouletier-Dilling","year":"2005","journal-title":"Hum Gene Ther."},{"issue":"7","key":"bib26-20210131","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1101\/gad.862101","article-title":"Ablation of NF1 function in neurons induces abnormal development of cerebral cortex and reactive gliosis in the brain","volume":"15","author":"Zhu","year":"2001","journal-title":"Genes Dev."},{"issue":"3-4","key":"bib27-20210131","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/1526-968X(200011\/12)28:3\/4<147::AID-GENE90>3.0.CO;2-G","article-title":"Z\/EG, a double reporter mouse line that expresses enhanced green fluorescent protein upon Cre-mediated excision","volume":"28","author":"Novak","year":"2000","journal-title":"Genesis."},{"issue":"7","key":"bib28-20210131","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1111\/j.1463-1326.2009.01193.x","article-title":"Additive actions of the cannabinoid and neuropeptide Y systems on adiposity and lipid oxidation","volume":"12","author":"Zhang","year":"2010","journal-title":"Diabetes Obes Metab."},{"issue":"1","key":"bib29-20210131","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.taap.2007.02.005","article-title":"Various effects of antidepressant drugs on bone microarchitectecture, mechanical properties and bone remodeling","volume":"221","author":"Bonnet","year":"2007","journal-title":"Toxicol Appl Pharmacol."},{"issue":"1","key":"bib30-20210131","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/jor.20481","article-title":"Modeling bone morphogenetic protein and bisphosphonate combination therapy in wild-type and Nf1 haploinsufficient mice","volume":"26","author":"Schindeler","year":"2008","journal-title":"J Ortop Res."},{"issue":"23","key":"bib31-20210131","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1093\/hmg\/ddt333","article-title":"Hyperactive Ras\/MAPK signaling is critical for tibial nonunion fracture in neurofibromin-deficient mice","volume":"22","author":"Sharma","year":"2013","journal-title":"Hum Mol Genet."},{"issue":"1-2","key":"bib32-20210131","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0014-5793(01)02651-5","article-title":"Effects of MAP kinase cascade inhibitors on the MKK5\/ERK5 pathway","volume":"502","author":"Mody","year":"2001","journal-title":"FEBS Lett."},{"issue":"4","key":"bib33-20210131","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.bone.2012.07.011","article-title":"Deterioration of fracture healing in the mouse model of NF1 long bone dysplasia","volume":"51","author":"El Khassawna","year":"2012","journal-title":"Bone."},{"issue":"10","key":"bib34-20210131","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jor.22121","article-title":"Is double inactivation of the Nf1 gene responsible for the development of congenital pseudarthrosis of the tibia associated with NF1?","volume":"30","author":"Lee","year":"2012","journal-title":"J Orthop Res."},{"issue":"4","key":"bib35-20210131","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00776-007-1142-1","article-title":"Congenital pseudarthrosis of the tibia: analysis of the histology and the NF1 gene","volume":"12","author":"Sakamoto","year":"2007","journal-title":"J Orthop Sci."},{"issue":"12","key":"bib36-20210131","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.2106\/JBJS.H.00014","article-title":"Biologic characteristics of fibrous hamartoma from congenital pseudarthrosis of the tibia associated with neurofibromatosis type 1","volume":"90","author":"Cho","year":"2008","journal-title":"J Bone Joint Surg Am."},{"issue":"8","key":"bib37-20210131","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1302\/0301-620X.93B8.25940","article-title":"Distal tibial fracture repair in a neurofibromatosis type 1-deficient mouse treated with recombinant bone morphogenetic protein and a bisphosphonate","volume":"93","author":"Schindeler","year":"2011","journal-title":"J Bone Joint Surg Br."},{"issue":"6","key":"bib38-20210131","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s11832-010-0293-3","article-title":"Preliminary experience with the combined use of recombinant bone morphogenetic protein and bisphosphonates in the treatment of congenital pseudarthrosis of the tibia","volume":"4","author":"Birke","year":"2010","journal-title":"J Child Orthop."},{"issue":"7","key":"bib39-20210131","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/jbmr.42","article-title":"Local low-dose lovastatin delivery improves the bone-healing defect caused by Nf1 loss of function in osteoblasts","volume":"25","author":"Wang","year":"2010","journal-title":"J Bone Miner Res."}],"container-title":["Journal of Bone and Joint Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00004623-201407160-00012","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T13:26:23Z","timestamp":1787750783000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00004623-201407160-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,7,16]]},"references-count":39,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.2106\/jbjs.m.00862","relation":{},"ISSN":["0021-9355","1535-1386"],"issn-type":[{"value":"0021-9355","type":"print"},{"value":"1535-1386","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,7,16]]}}}